ANGELA CHEATHAM: Open Payments
NPI 1487876546 · MIDLOTHIAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 27 payments from 9 companies in 2025. Trend: 2023 $335 · 2024 $488 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $157 |
| GlaxoSmithKline, LLC. | 5 | $125 |
| Lilly USA, LLC | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| PFIZER INC. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: TRELEGY ELLIPTA, Ozempic, Wegovy, JARDIANCE, MOUNJARO, AIRSUPRA, PREVNAR 20, FREESTYLE LIBRE.
Industry payments across TX — which companies pay providers there.
